• No results found

Neoadjuvant Chemotherapy (NACT)

Role of Neoadjuvant Chemotherapy in Treatment of Cervical Cancer: A Case Series of Thirty Eight Patients Treated at Bangabandhu Sheikh Mujib Medical University in Dhaka, Bangladesh

Role of Neoadjuvant Chemotherapy in Treatment of Cervical Cancer: A Case Series of Thirty Eight Patients Treated at Bangabandhu Sheikh Mujib Medical University in Dhaka, Bangladesh

... of NACT because of the range of therapies and post chemothera- py treatment [27] [28] ...showed NACT followed by surgery resulted in a reduction in the risk of death by 35% with a gain of 14% in the 5-year ...

10

The use of ultrasound in the clinical re-staging of the axilla after neoadjuvant chemotherapy (NACT).

The use of ultrasound in the clinical re-staging of the axilla after neoadjuvant chemotherapy (NACT).

... Concurrently, neoadjuvant chemotherapy (NACT) has a continuously increasing role in a) converting inoperable to operable and b) downsizing the primary cancer to enable breast conserving surgery (BCS) ...

13

Evaluating the benefits of neoadjuvant chemotherapy for advanced epithelial ovarian cancer: a retrospective study

Evaluating the benefits of neoadjuvant chemotherapy for advanced epithelial ovarian cancer: a retrospective study

... with neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS) or primary debulking surgery ...from NACT were further ...underwent NACT followed by IDS or PDS from ...

8

BACCHUS: A randomised non-comparative phase II study of neoadjuvant chemotherapy (NACT) in patients with locally advanced rectal cancer (LARC)

BACCHUS: A randomised non-comparative phase II study of neoadjuvant chemotherapy (NACT) in patients with locally advanced rectal cancer (LARC)

... in NACT have had heterogeneous inclusion criteria, few pa- tients and uncertain surgical and MRI ...the neoadjuvant setting and suggest that delivering neoadjuvant chemotherapy could be as e ff ...

30

Magnetic resonance imaging apparent diffusion coefficient before and after neoadjuvant
  chemotherapy in patients with breast cancer and its correlation with tumor load

Magnetic resonance imaging apparent diffusion coefficient before and after neoadjuvant chemotherapy in patients with breast cancer and its correlation with tumor load

... preoperative neoadjuvant chemotherapy or not in medical ...received neoadjuvant chemotherapy before the operation and were 42-65 years old, 33 cases were at tumor stage II and 25 cases were at ...

5

Neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a feasibility and safety study

Neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a feasibility and safety study

... adjuvant chemotherapy has been the logical treatment for preventing hematogenous and lymphogenous ...that neoadjuvant chemotherapy confers survival benefits in other tumors [16–19], and on this ...

7

Controversies and consensus of neoadjuvant chemotherapy in soft-tissue sarcomas

Controversies and consensus of neoadjuvant chemotherapy in soft-tissue sarcomas

... that neoadjuvant chemotherapy might be even more bene- ficial than conventional postsurgical adjuvant chemo- ...adjuvant chemotherapy is avoidance of development of genetic heterogeneity and associ- ...

6

Neoadjuvant chemotherapy with radical surgery vs radical surgery alone for cervical cancer: a systematic review and meta-analysis

<p>Neoadjuvant chemotherapy with radical surgery vs radical surgery alone for cervical cancer: a systematic review and meta-analysis</p>

... on neoadjuvant chemotherapy for cervical cancer, but the results ...of neoadjuvant che- motherapy followed by surgery vs surgery alone for patients with early-stage or locally advanced cervical ...

11

Influence of neoadjuvant chemotherapy on prognosis of patients with synovial sarcoma

Influence of neoadjuvant chemotherapy on prognosis of patients with synovial sarcoma

... received neoadjuvant chemotherapy and 9 received adjuvant chemotherapy; the 5-year OS was ...that neoadjuvant chemotherapy could bring more bene- fits for patients with synovial sarcoma ...

7

Effect of neoadjuvant chemotherapy and its correlation with HPV status, EGFR, Her 2 neu, and GADD45 expression in oral squamous cell carcinoma

Effect of neoadjuvant chemotherapy and its correlation with HPV status, EGFR, Her 2 neu, and GADD45 expression in oral squamous cell carcinoma

... with neoadjuvant chemotherapy suggesting its utility in borderline operable ...of chemotherapy does not appear to be related to the expression of EGFR, Her-2-Neu, and GADD45 protein or presence of ...

10

Pathological evaluation of neoadjuvant chemotherapy in advanced gastric cancer

Pathological evaluation of neoadjuvant chemotherapy in advanced gastric cancer

... after chemotherapy does not independently affect patient survival and that it only affects survival signifi- cantly when chemotherapy-induced tumor necrosis sig- nificantly induces ...from ...

11

Trends and disparities in the use of neoadjuvant chemotherapy for muscle invasive urothelial carcinoma

Trends and disparities in the use of neoadjuvant chemotherapy for muscle invasive urothelial carcinoma

... years, neoadjuvant chemotherapy prior to RC has been recognized to provide a significant improvement in overall survival in patients with ...based chemotherapy prior to RC 2 ...

11

Nodular Regenerative Hyperplasia Secondary to Neoadjuvant Chemotherapy for Colorectal Liver Metastases

Nodular Regenerative Hyperplasia Secondary to Neoadjuvant Chemotherapy for Colorectal Liver Metastases

... Oxaliplatin-based chemotherapy has a toxic e ff ect on sinusoidal endothelial cells resulting in sinusoidal dilatation, congestion, and ...between neoadjuvant chemotherapy and surgical resection ...

5

Significant benefits of adding neoadjuvant chemotherapy before concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis of randomized controlled trials

Significant benefits of adding neoadjuvant chemotherapy before concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis of randomized controlled trials

... Risk of bias was independently assessed by two authors, based on the guidelines outlined in the Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [27]. Disagreements were resolved by consensus with ...

16

PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer.

PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer.

... We acknowledge that our study has a number of limitations. EXPERT and EXPERT-C were sequential trials that spanned over a period of 7 years. Differences in terms of treatment and procedures between these trials as well ...

23

Neoadjuvant chemotherapy followed by fast-track cytoreductive surgery plus short-course hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced ovarian cancer: preliminary results of a promising all-in-one approach

Neoadjuvant chemotherapy followed by fast-track cytoreductive surgery plus short-course hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced ovarian cancer: preliminary results of a promising all-in-one approach

... to chemotherapy and progression were defined according to the Response Evaluation Criteria in Solid Tumors (RECIST) and the Gynecologic Cancer Intergroup (GCIG) ...of NACT until the date of first ...

10

Neoadjuvant chemotherapy among patients treated for nonmetastatic breast cancer in a population with a high HIV prevalence in Johannesburg, South Africa

Neoadjuvant chemotherapy among patients treated for nonmetastatic breast cancer in a population with a high HIV prevalence in Johannesburg, South Africa

... Background: Neoadjuvant (primary) chemotherapy (NACT) is the standard of care for locally advanced breast ...of chemotherapy response; a pathological complete responses correspond to improved ...

8

Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases

Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases

... Surgery was performed 4 weeks after the last cycle of oxaliplatin-based chemotherapy or 6 weeks after the last bevacizumab cycle [19, 20]. Provided that R0 resection was deemed possible, surgery was performed ...

9

A Six-Epithelial&ndash;Mesenchymal Transition Gene Signature May Predict Metastasis of Triple-Negative Breast Cancer

<p>A Six-Epithelial&ndash;Mesenchymal Transition Gene Signature May Predict Metastasis of Triple-Negative Breast Cancer</p>

... to chemotherapy, alone or in combination with poly (ADP-ribose) polymerase (PARP) inhibitors in patients with germline breast cancer gene (BRCA) ...particular, neoadjuvant chemotherapy (NACT) ...

13

The benefit of taxane-based therapies over fluoropyrimidine plus platinum (FP) in the treatment of esophageal cancer: a meta-analysis of clinical studies

<p>The benefit of taxane-based therapies over fluoropyrimidine plus platinum (FP) in the treatment of esophageal cancer: a meta-analysis of clinical studies</p>

... FP chemotherapy in ...received neoadjuvant chemotherapy (NACT), neoadjuvant chemoradiotherapy (NACRT), or definitive chemoradiotherapy ...taxane-based NACT (progression-free ...

15

Show all 4078 documents...

Related subjects